Trials / Not Yet Recruiting
Not Yet RecruitingNCT07133412
An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph
An Evaluation of the Neuromuscular Junction in Infants Using Train-of-four Monitoring With the TetraGraph™ Neuromuscular Transmission Monitor
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Joseph D. Tobias · Academic / Other
- Sex
- All
- Age
- 28 Days – 25 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to use electromyography-based train-of-four monitoring (TetraGraph™ Neuromuscular Transmission Monitor) as a means of evaluating differences in neuromuscular transmission between infants ≤ 3 months of age and adolescent and older patients (≥ 12 years of age).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TetraGraph | TetraGraph is a unique, EMG-based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block. |
Timeline
- Start date
- 2026-07-01
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2025-08-21
- Last updated
- 2026-04-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07133412. Inclusion in this directory is not an endorsement.